Research ArticleHuman Study
Dosimetric Evaluation of Immunoscintigraphy Using Indium-111-Labeled Monoclonal Antibody Fragments in Patients with Ovarian Cancer
Wilhelmina C.A.M. Buijs, Leon F.A.G. Massuger, Roland A.M.J. Claessens, Peter Kenemans and Frans H. M. Corstens
Journal of Nuclear Medicine June 1992, 33 (6) 1113-1120;
Wilhelmina C.A.M. Buijs
Leon F.A.G. Massuger
Roland A.M.J. Claessens
Peter Kenemans


This is a PDF-only article. The first page of the PDF of this article appears above.
In this issue
Dosimetric Evaluation of Immunoscintigraphy Using Indium-111-Labeled Monoclonal Antibody Fragments in Patients with Ovarian Cancer
Wilhelmina C.A.M. Buijs, Leon F.A.G. Massuger, Roland A.M.J. Claessens, Peter Kenemans, Frans H. M. Corstens
Journal of Nuclear Medicine Jun 1992, 33 (6) 1113-1120;
Jump to section
Related Articles
- No related articles found.
Cited By...
- Whole-body PET imaging of SIV using anti-Env probes fails to reveal regions of specific uptake in rhesus macaques
- Antitumor Effects of a Human Dimeric Antibody Fragment 131I-AFRA-DFM5.3 in a Mouse Model for Ovarian Cancer
- 99mTc-Labeled Interleukin 8 for the Scintigraphic Detection of Infection and Inflammation: First Clinical Evaluation
- Linear Regression Model for Predicting Patient-Specific Total Skeletal Spongiosa Volume for Use in Molecular Radiotherapy Dosimetry
- Radioimmunotherapy with [131I]cG250 in Patients with Metastasized Renal Cell Cancer: Dosimetric Analysis and Immunologic Response
- Targeting of Metastatic Renal Cell Carcinoma with the Chimeric Monoclonal Antibody G250 Labeled with 131I or 111In: An Intrapatient Comparison
- Chemical Design of Radiolabeled Antibody Fragments for Low Renal Radioactivity Levels